Medical Care
Global Plague Therapeutics Market Research Report 2025
- Jul 08, 25
- ID: 348208
- Pages: 109
- Figures: 108
- Views: 1
The global market for Plague Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Plague Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plague Therapeutics.
The Plague Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plague Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plague Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CordenPharma
Cipher Pharmaceuticals
Pfizer
Bayer HealthCare
Eli Lilly
Achaogen
Aurobindo Pharma
GlaxoSmithKline
Bristol-Myers Squibb
Aspen Pharmacare
Biocon
Astellas Pharma
Melinta Therapeutics
Basilea Pharmaceutica
Allergan
Abbott
AstraZeneca
AmpliPhi Biosciences
Actelion Pharmaceuticals
Chiesi Farmaceutici
Exoxemis
Merck
DynPort Vaccine Company LLC
Segment by Type
Vaccine
Drugs
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plague Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Plague Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plague Therapeutics.
The Plague Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plague Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plague Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CordenPharma
Cipher Pharmaceuticals
Pfizer
Bayer HealthCare
Eli Lilly
Achaogen
Aurobindo Pharma
GlaxoSmithKline
Bristol-Myers Squibb
Aspen Pharmacare
Biocon
Astellas Pharma
Melinta Therapeutics
Basilea Pharmaceutica
Allergan
Abbott
AstraZeneca
AmpliPhi Biosciences
Actelion Pharmaceuticals
Chiesi Farmaceutici
Exoxemis
Merck
DynPort Vaccine Company LLC
Segment by Type
Vaccine
Drugs
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plague Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plague Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Vaccine
1.2.3 Drugs
1.3 Market by Application
1.3.1 Global Plague Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plague Therapeutics Market Perspective (2020-2031)
2.2 Global Plague Therapeutics Growth Trends by Region
2.2.1 Global Plague Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Plague Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Plague Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Plague Therapeutics Market Dynamics
2.3.1 Plague Therapeutics Industry Trends
2.3.2 Plague Therapeutics Market Drivers
2.3.3 Plague Therapeutics Market Challenges
2.3.4 Plague Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plague Therapeutics Players by Revenue
3.1.1 Global Top Plague Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Plague Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Plague Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Plague Therapeutics Revenue
3.4 Global Plague Therapeutics Market Concentration Ratio
3.4.1 Global Plague Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plague Therapeutics Revenue in 2024
3.5 Global Key Players of Plague Therapeutics Head office and Area Served
3.6 Global Key Players of Plague Therapeutics, Product and Application
3.7 Global Key Players of Plague Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Plague Therapeutics Breakdown Data by Type
4.1 Global Plague Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Plague Therapeutics Forecasted Market Size by Type (2026-2031)
5 Plague Therapeutics Breakdown Data by Application
5.1 Global Plague Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Plague Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Plague Therapeutics Market Size (2020-2031)
6.2 North America Plague Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Plague Therapeutics Market Size by Country (2020-2025)
6.4 North America Plague Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plague Therapeutics Market Size (2020-2031)
7.2 Europe Plague Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Plague Therapeutics Market Size by Country (2020-2025)
7.4 Europe Plague Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plague Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Plague Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Plague Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Plague Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plague Therapeutics Market Size (2020-2031)
9.2 Latin America Plague Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Plague Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Plague Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plague Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Plague Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Plague Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Plague Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CordenPharma
11.1.1 CordenPharma Company Details
11.1.2 CordenPharma Business Overview
11.1.3 CordenPharma Plague Therapeutics Introduction
11.1.4 CordenPharma Revenue in Plague Therapeutics Business (2020-2025)
11.1.5 CordenPharma Recent Development
11.2 Cipher Pharmaceuticals
11.2.1 Cipher Pharmaceuticals Company Details
11.2.2 Cipher Pharmaceuticals Business Overview
11.2.3 Cipher Pharmaceuticals Plague Therapeutics Introduction
11.2.4 Cipher Pharmaceuticals Revenue in Plague Therapeutics Business (2020-2025)
11.2.5 Cipher Pharmaceuticals Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Plague Therapeutics Introduction
11.3.4 Pfizer Revenue in Plague Therapeutics Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Bayer HealthCare
11.4.1 Bayer HealthCare Company Details
11.4.2 Bayer HealthCare Business Overview
11.4.3 Bayer HealthCare Plague Therapeutics Introduction
11.4.4 Bayer HealthCare Revenue in Plague Therapeutics Business (2020-2025)
11.4.5 Bayer HealthCare Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Plague Therapeutics Introduction
11.5.4 Eli Lilly Revenue in Plague Therapeutics Business (2020-2025)
11.5.5 Eli Lilly Recent Development
11.6 Achaogen
11.6.1 Achaogen Company Details
11.6.2 Achaogen Business Overview
11.6.3 Achaogen Plague Therapeutics Introduction
11.6.4 Achaogen Revenue in Plague Therapeutics Business (2020-2025)
11.6.5 Achaogen Recent Development
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Details
11.7.2 Aurobindo Pharma Business Overview
11.7.3 Aurobindo Pharma Plague Therapeutics Introduction
11.7.4 Aurobindo Pharma Revenue in Plague Therapeutics Business (2020-2025)
11.7.5 Aurobindo Pharma Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Plague Therapeutics Introduction
11.8.4 GlaxoSmithKline Revenue in Plague Therapeutics Business (2020-2025)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Plague Therapeutics Introduction
11.9.4 Bristol-Myers Squibb Revenue in Plague Therapeutics Business (2020-2025)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Aspen Pharmacare
11.10.1 Aspen Pharmacare Company Details
11.10.2 Aspen Pharmacare Business Overview
11.10.3 Aspen Pharmacare Plague Therapeutics Introduction
11.10.4 Aspen Pharmacare Revenue in Plague Therapeutics Business (2020-2025)
11.10.5 Aspen Pharmacare Recent Development
11.11 Biocon
11.11.1 Biocon Company Details
11.11.2 Biocon Business Overview
11.11.3 Biocon Plague Therapeutics Introduction
11.11.4 Biocon Revenue in Plague Therapeutics Business (2020-2025)
11.11.5 Biocon Recent Development
11.12 Astellas Pharma
11.12.1 Astellas Pharma Company Details
11.12.2 Astellas Pharma Business Overview
11.12.3 Astellas Pharma Plague Therapeutics Introduction
11.12.4 Astellas Pharma Revenue in Plague Therapeutics Business (2020-2025)
11.12.5 Astellas Pharma Recent Development
11.13 Melinta Therapeutics
11.13.1 Melinta Therapeutics Company Details
11.13.2 Melinta Therapeutics Business Overview
11.13.3 Melinta Therapeutics Plague Therapeutics Introduction
11.13.4 Melinta Therapeutics Revenue in Plague Therapeutics Business (2020-2025)
11.13.5 Melinta Therapeutics Recent Development
11.14 Basilea Pharmaceutica
11.14.1 Basilea Pharmaceutica Company Details
11.14.2 Basilea Pharmaceutica Business Overview
11.14.3 Basilea Pharmaceutica Plague Therapeutics Introduction
11.14.4 Basilea Pharmaceutica Revenue in Plague Therapeutics Business (2020-2025)
11.14.5 Basilea Pharmaceutica Recent Development
11.15 Allergan
11.15.1 Allergan Company Details
11.15.2 Allergan Business Overview
11.15.3 Allergan Plague Therapeutics Introduction
11.15.4 Allergan Revenue in Plague Therapeutics Business (2020-2025)
11.15.5 Allergan Recent Development
11.16 Abbott
11.16.1 Abbott Company Details
11.16.2 Abbott Business Overview
11.16.3 Abbott Plague Therapeutics Introduction
11.16.4 Abbott Revenue in Plague Therapeutics Business (2020-2025)
11.16.5 Abbott Recent Development
11.17 AstraZeneca
11.17.1 AstraZeneca Company Details
11.17.2 AstraZeneca Business Overview
11.17.3 AstraZeneca Plague Therapeutics Introduction
11.17.4 AstraZeneca Revenue in Plague Therapeutics Business (2020-2025)
11.17.5 AstraZeneca Recent Development
11.18 AmpliPhi Biosciences
11.18.1 AmpliPhi Biosciences Company Details
11.18.2 AmpliPhi Biosciences Business Overview
11.18.3 AmpliPhi Biosciences Plague Therapeutics Introduction
11.18.4 AmpliPhi Biosciences Revenue in Plague Therapeutics Business (2020-2025)
11.18.5 AmpliPhi Biosciences Recent Development
11.19 Actelion Pharmaceuticals
11.19.1 Actelion Pharmaceuticals Company Details
11.19.2 Actelion Pharmaceuticals Business Overview
11.19.3 Actelion Pharmaceuticals Plague Therapeutics Introduction
11.19.4 Actelion Pharmaceuticals Revenue in Plague Therapeutics Business (2020-2025)
11.19.5 Actelion Pharmaceuticals Recent Development
11.20 Chiesi Farmaceutici
11.20.1 Chiesi Farmaceutici Company Details
11.20.2 Chiesi Farmaceutici Business Overview
11.20.3 Chiesi Farmaceutici Plague Therapeutics Introduction
11.20.4 Chiesi Farmaceutici Revenue in Plague Therapeutics Business (2020-2025)
11.20.5 Chiesi Farmaceutici Recent Development
11.21 Exoxemis
11.21.1 Exoxemis Company Details
11.21.2 Exoxemis Business Overview
11.21.3 Exoxemis Plague Therapeutics Introduction
11.21.4 Exoxemis Revenue in Plague Therapeutics Business (2020-2025)
11.21.5 Exoxemis Recent Development
11.22 Merck
11.22.1 Merck Company Details
11.22.2 Merck Business Overview
11.22.3 Merck Plague Therapeutics Introduction
11.22.4 Merck Revenue in Plague Therapeutics Business (2020-2025)
11.22.5 Merck Recent Development
11.23 DynPort Vaccine Company LLC
11.23.1 DynPort Vaccine Company LLC Company Details
11.23.2 DynPort Vaccine Company LLC Business Overview
11.23.3 DynPort Vaccine Company LLC Plague Therapeutics Introduction
11.23.4 DynPort Vaccine Company LLC Revenue in Plague Therapeutics Business (2020-2025)
11.23.5 DynPort Vaccine Company LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plague Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Vaccine
1.2.3 Drugs
1.3 Market by Application
1.3.1 Global Plague Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plague Therapeutics Market Perspective (2020-2031)
2.2 Global Plague Therapeutics Growth Trends by Region
2.2.1 Global Plague Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Plague Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Plague Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Plague Therapeutics Market Dynamics
2.3.1 Plague Therapeutics Industry Trends
2.3.2 Plague Therapeutics Market Drivers
2.3.3 Plague Therapeutics Market Challenges
2.3.4 Plague Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plague Therapeutics Players by Revenue
3.1.1 Global Top Plague Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Plague Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Plague Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Plague Therapeutics Revenue
3.4 Global Plague Therapeutics Market Concentration Ratio
3.4.1 Global Plague Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plague Therapeutics Revenue in 2024
3.5 Global Key Players of Plague Therapeutics Head office and Area Served
3.6 Global Key Players of Plague Therapeutics, Product and Application
3.7 Global Key Players of Plague Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Plague Therapeutics Breakdown Data by Type
4.1 Global Plague Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Plague Therapeutics Forecasted Market Size by Type (2026-2031)
5 Plague Therapeutics Breakdown Data by Application
5.1 Global Plague Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Plague Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Plague Therapeutics Market Size (2020-2031)
6.2 North America Plague Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Plague Therapeutics Market Size by Country (2020-2025)
6.4 North America Plague Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plague Therapeutics Market Size (2020-2031)
7.2 Europe Plague Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Plague Therapeutics Market Size by Country (2020-2025)
7.4 Europe Plague Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plague Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Plague Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Plague Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Plague Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plague Therapeutics Market Size (2020-2031)
9.2 Latin America Plague Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Plague Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Plague Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plague Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Plague Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Plague Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Plague Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CordenPharma
11.1.1 CordenPharma Company Details
11.1.2 CordenPharma Business Overview
11.1.3 CordenPharma Plague Therapeutics Introduction
11.1.4 CordenPharma Revenue in Plague Therapeutics Business (2020-2025)
11.1.5 CordenPharma Recent Development
11.2 Cipher Pharmaceuticals
11.2.1 Cipher Pharmaceuticals Company Details
11.2.2 Cipher Pharmaceuticals Business Overview
11.2.3 Cipher Pharmaceuticals Plague Therapeutics Introduction
11.2.4 Cipher Pharmaceuticals Revenue in Plague Therapeutics Business (2020-2025)
11.2.5 Cipher Pharmaceuticals Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Plague Therapeutics Introduction
11.3.4 Pfizer Revenue in Plague Therapeutics Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Bayer HealthCare
11.4.1 Bayer HealthCare Company Details
11.4.2 Bayer HealthCare Business Overview
11.4.3 Bayer HealthCare Plague Therapeutics Introduction
11.4.4 Bayer HealthCare Revenue in Plague Therapeutics Business (2020-2025)
11.4.5 Bayer HealthCare Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Plague Therapeutics Introduction
11.5.4 Eli Lilly Revenue in Plague Therapeutics Business (2020-2025)
11.5.5 Eli Lilly Recent Development
11.6 Achaogen
11.6.1 Achaogen Company Details
11.6.2 Achaogen Business Overview
11.6.3 Achaogen Plague Therapeutics Introduction
11.6.4 Achaogen Revenue in Plague Therapeutics Business (2020-2025)
11.6.5 Achaogen Recent Development
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Details
11.7.2 Aurobindo Pharma Business Overview
11.7.3 Aurobindo Pharma Plague Therapeutics Introduction
11.7.4 Aurobindo Pharma Revenue in Plague Therapeutics Business (2020-2025)
11.7.5 Aurobindo Pharma Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Plague Therapeutics Introduction
11.8.4 GlaxoSmithKline Revenue in Plague Therapeutics Business (2020-2025)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Plague Therapeutics Introduction
11.9.4 Bristol-Myers Squibb Revenue in Plague Therapeutics Business (2020-2025)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Aspen Pharmacare
11.10.1 Aspen Pharmacare Company Details
11.10.2 Aspen Pharmacare Business Overview
11.10.3 Aspen Pharmacare Plague Therapeutics Introduction
11.10.4 Aspen Pharmacare Revenue in Plague Therapeutics Business (2020-2025)
11.10.5 Aspen Pharmacare Recent Development
11.11 Biocon
11.11.1 Biocon Company Details
11.11.2 Biocon Business Overview
11.11.3 Biocon Plague Therapeutics Introduction
11.11.4 Biocon Revenue in Plague Therapeutics Business (2020-2025)
11.11.5 Biocon Recent Development
11.12 Astellas Pharma
11.12.1 Astellas Pharma Company Details
11.12.2 Astellas Pharma Business Overview
11.12.3 Astellas Pharma Plague Therapeutics Introduction
11.12.4 Astellas Pharma Revenue in Plague Therapeutics Business (2020-2025)
11.12.5 Astellas Pharma Recent Development
11.13 Melinta Therapeutics
11.13.1 Melinta Therapeutics Company Details
11.13.2 Melinta Therapeutics Business Overview
11.13.3 Melinta Therapeutics Plague Therapeutics Introduction
11.13.4 Melinta Therapeutics Revenue in Plague Therapeutics Business (2020-2025)
11.13.5 Melinta Therapeutics Recent Development
11.14 Basilea Pharmaceutica
11.14.1 Basilea Pharmaceutica Company Details
11.14.2 Basilea Pharmaceutica Business Overview
11.14.3 Basilea Pharmaceutica Plague Therapeutics Introduction
11.14.4 Basilea Pharmaceutica Revenue in Plague Therapeutics Business (2020-2025)
11.14.5 Basilea Pharmaceutica Recent Development
11.15 Allergan
11.15.1 Allergan Company Details
11.15.2 Allergan Business Overview
11.15.3 Allergan Plague Therapeutics Introduction
11.15.4 Allergan Revenue in Plague Therapeutics Business (2020-2025)
11.15.5 Allergan Recent Development
11.16 Abbott
11.16.1 Abbott Company Details
11.16.2 Abbott Business Overview
11.16.3 Abbott Plague Therapeutics Introduction
11.16.4 Abbott Revenue in Plague Therapeutics Business (2020-2025)
11.16.5 Abbott Recent Development
11.17 AstraZeneca
11.17.1 AstraZeneca Company Details
11.17.2 AstraZeneca Business Overview
11.17.3 AstraZeneca Plague Therapeutics Introduction
11.17.4 AstraZeneca Revenue in Plague Therapeutics Business (2020-2025)
11.17.5 AstraZeneca Recent Development
11.18 AmpliPhi Biosciences
11.18.1 AmpliPhi Biosciences Company Details
11.18.2 AmpliPhi Biosciences Business Overview
11.18.3 AmpliPhi Biosciences Plague Therapeutics Introduction
11.18.4 AmpliPhi Biosciences Revenue in Plague Therapeutics Business (2020-2025)
11.18.5 AmpliPhi Biosciences Recent Development
11.19 Actelion Pharmaceuticals
11.19.1 Actelion Pharmaceuticals Company Details
11.19.2 Actelion Pharmaceuticals Business Overview
11.19.3 Actelion Pharmaceuticals Plague Therapeutics Introduction
11.19.4 Actelion Pharmaceuticals Revenue in Plague Therapeutics Business (2020-2025)
11.19.5 Actelion Pharmaceuticals Recent Development
11.20 Chiesi Farmaceutici
11.20.1 Chiesi Farmaceutici Company Details
11.20.2 Chiesi Farmaceutici Business Overview
11.20.3 Chiesi Farmaceutici Plague Therapeutics Introduction
11.20.4 Chiesi Farmaceutici Revenue in Plague Therapeutics Business (2020-2025)
11.20.5 Chiesi Farmaceutici Recent Development
11.21 Exoxemis
11.21.1 Exoxemis Company Details
11.21.2 Exoxemis Business Overview
11.21.3 Exoxemis Plague Therapeutics Introduction
11.21.4 Exoxemis Revenue in Plague Therapeutics Business (2020-2025)
11.21.5 Exoxemis Recent Development
11.22 Merck
11.22.1 Merck Company Details
11.22.2 Merck Business Overview
11.22.3 Merck Plague Therapeutics Introduction
11.22.4 Merck Revenue in Plague Therapeutics Business (2020-2025)
11.22.5 Merck Recent Development
11.23 DynPort Vaccine Company LLC
11.23.1 DynPort Vaccine Company LLC Company Details
11.23.2 DynPort Vaccine Company LLC Business Overview
11.23.3 DynPort Vaccine Company LLC Plague Therapeutics Introduction
11.23.4 DynPort Vaccine Company LLC Revenue in Plague Therapeutics Business (2020-2025)
11.23.5 DynPort Vaccine Company LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Plague Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Vaccine
Table 3. Key Players of Drugs
Table 4. Global Plague Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Plague Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Plague Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Plague Therapeutics Market Share by Region (2020-2025)
Table 8. Global Plague Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Plague Therapeutics Market Share by Region (2026-2031)
Table 10. Plague Therapeutics Market Trends
Table 11. Plague Therapeutics Market Drivers
Table 12. Plague Therapeutics Market Challenges
Table 13. Plague Therapeutics Market Restraints
Table 14. Global Plague Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Plague Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Plague Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plague Therapeutics as of 2024)
Table 17. Ranking of Global Top Plague Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Plague Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Plague Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Plague Therapeutics, Product and Application
Table 21. Global Key Players of Plague Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plague Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Plague Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Plague Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Plague Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Plague Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Plague Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Plague Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Plague Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Plague Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Plague Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Plague Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Plague Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Plague Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Plague Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Plague Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Plague Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Plague Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Plague Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Plague Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Plague Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Plague Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Plague Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Plague Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. CordenPharma Company Details
Table 47. CordenPharma Business Overview
Table 48. CordenPharma Plague Therapeutics Product
Table 49. CordenPharma Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 50. CordenPharma Recent Development
Table 51. Cipher Pharmaceuticals Company Details
Table 52. Cipher Pharmaceuticals Business Overview
Table 53. Cipher Pharmaceuticals Plague Therapeutics Product
Table 54. Cipher Pharmaceuticals Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Cipher Pharmaceuticals Recent Development
Table 56. Pfizer Company Details
Table 57. Pfizer Business Overview
Table 58. Pfizer Plague Therapeutics Product
Table 59. Pfizer Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Bayer HealthCare Company Details
Table 62. Bayer HealthCare Business Overview
Table 63. Bayer HealthCare Plague Therapeutics Product
Table 64. Bayer HealthCare Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Bayer HealthCare Recent Development
Table 66. Eli Lilly Company Details
Table 67. Eli Lilly Business Overview
Table 68. Eli Lilly Plague Therapeutics Product
Table 69. Eli Lilly Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 70. Eli Lilly Recent Development
Table 71. Achaogen Company Details
Table 72. Achaogen Business Overview
Table 73. Achaogen Plague Therapeutics Product
Table 74. Achaogen Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Achaogen Recent Development
Table 76. Aurobindo Pharma Company Details
Table 77. Aurobindo Pharma Business Overview
Table 78. Aurobindo Pharma Plague Therapeutics Product
Table 79. Aurobindo Pharma Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Aurobindo Pharma Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Plague Therapeutics Product
Table 84. GlaxoSmithKline Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Plague Therapeutics Product
Table 89. Bristol-Myers Squibb Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Development
Table 91. Aspen Pharmacare Company Details
Table 92. Aspen Pharmacare Business Overview
Table 93. Aspen Pharmacare Plague Therapeutics Product
Table 94. Aspen Pharmacare Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Aspen Pharmacare Recent Development
Table 96. Biocon Company Details
Table 97. Biocon Business Overview
Table 98. Biocon Plague Therapeutics Product
Table 99. Biocon Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Biocon Recent Development
Table 101. Astellas Pharma Company Details
Table 102. Astellas Pharma Business Overview
Table 103. Astellas Pharma Plague Therapeutics Product
Table 104. Astellas Pharma Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 105. Astellas Pharma Recent Development
Table 106. Melinta Therapeutics Company Details
Table 107. Melinta Therapeutics Business Overview
Table 108. Melinta Therapeutics Plague Therapeutics Product
Table 109. Melinta Therapeutics Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 110. Melinta Therapeutics Recent Development
Table 111. Basilea Pharmaceutica Company Details
Table 112. Basilea Pharmaceutica Business Overview
Table 113. Basilea Pharmaceutica Plague Therapeutics Product
Table 114. Basilea Pharmaceutica Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 115. Basilea Pharmaceutica Recent Development
Table 116. Allergan Company Details
Table 117. Allergan Business Overview
Table 118. Allergan Plague Therapeutics Product
Table 119. Allergan Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 120. Allergan Recent Development
Table 121. Abbott Company Details
Table 122. Abbott Business Overview
Table 123. Abbott Plague Therapeutics Product
Table 124. Abbott Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 125. Abbott Recent Development
Table 126. AstraZeneca Company Details
Table 127. AstraZeneca Business Overview
Table 128. AstraZeneca Plague Therapeutics Product
Table 129. AstraZeneca Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 130. AstraZeneca Recent Development
Table 131. AmpliPhi Biosciences Company Details
Table 132. AmpliPhi Biosciences Business Overview
Table 133. AmpliPhi Biosciences Plague Therapeutics Product
Table 134. AmpliPhi Biosciences Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 135. AmpliPhi Biosciences Recent Development
Table 136. Actelion Pharmaceuticals Company Details
Table 137. Actelion Pharmaceuticals Business Overview
Table 138. Actelion Pharmaceuticals Plague Therapeutics Product
Table 139. Actelion Pharmaceuticals Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 140. Actelion Pharmaceuticals Recent Development
Table 141. Chiesi Farmaceutici Company Details
Table 142. Chiesi Farmaceutici Business Overview
Table 143. Chiesi Farmaceutici Plague Therapeutics Product
Table 144. Chiesi Farmaceutici Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 145. Chiesi Farmaceutici Recent Development
Table 146. Exoxemis Company Details
Table 147. Exoxemis Business Overview
Table 148. Exoxemis Plague Therapeutics Product
Table 149. Exoxemis Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 150. Exoxemis Recent Development
Table 151. Merck Company Details
Table 152. Merck Business Overview
Table 153. Merck Plague Therapeutics Product
Table 154. Merck Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 155. Merck Recent Development
Table 156. DynPort Vaccine Company LLC Company Details
Table 157. DynPort Vaccine Company LLC Business Overview
Table 158. DynPort Vaccine Company LLC Plague Therapeutics Product
Table 159. DynPort Vaccine Company LLC Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 160. DynPort Vaccine Company LLC Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 164. Authors List of This Report
List of Figures
Figure 1. Plague Therapeutics Picture
Figure 2. Global Plague Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Plague Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Vaccine Features
Figure 5. Drugs Features
Figure 6. Global Plague Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Plague Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Plague Therapeutics Report Years Considered
Figure 12. Global Plague Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Plague Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Plague Therapeutics Market Share by Region: 2024 VS 2031
Figure 15. Global Plague Therapeutics Market Share by Players in 2024
Figure 16. Global Top Plague Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plague Therapeutics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Plague Therapeutics Revenue in 2024
Figure 18. North America Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Plague Therapeutics Market Share by Country (2020-2031)
Figure 20. United States Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Plague Therapeutics Market Share by Country (2020-2031)
Figure 24. Germany Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Plague Therapeutics Market Share by Region (2020-2031)
Figure 32. China Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Plague Therapeutics Market Share by Country (2020-2031)
Figure 40. Mexico Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Plague Therapeutics Market Share by Country (2020-2031)
Figure 44. Turkey Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. CordenPharma Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 48. Cipher Pharmaceuticals Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 50. Bayer HealthCare Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 51. Eli Lilly Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 52. Achaogen Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 53. Aurobindo Pharma Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 56. Aspen Pharmacare Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 57. Biocon Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 58. Astellas Pharma Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 59. Melinta Therapeutics Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 60. Basilea Pharmaceutica Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 61. Allergan Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 62. Abbott Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 63. AstraZeneca Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 64. AmpliPhi Biosciences Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 65. Actelion Pharmaceuticals Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 66. Chiesi Farmaceutici Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 67. Exoxemis Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 68. Merck Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 69. DynPort Vaccine Company LLC Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global Plague Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Vaccine
Table 3. Key Players of Drugs
Table 4. Global Plague Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Plague Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Plague Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Plague Therapeutics Market Share by Region (2020-2025)
Table 8. Global Plague Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Plague Therapeutics Market Share by Region (2026-2031)
Table 10. Plague Therapeutics Market Trends
Table 11. Plague Therapeutics Market Drivers
Table 12. Plague Therapeutics Market Challenges
Table 13. Plague Therapeutics Market Restraints
Table 14. Global Plague Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Plague Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Plague Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plague Therapeutics as of 2024)
Table 17. Ranking of Global Top Plague Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Plague Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Plague Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Plague Therapeutics, Product and Application
Table 21. Global Key Players of Plague Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plague Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Plague Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Plague Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Plague Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Plague Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Plague Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Plague Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Plague Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Plague Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Plague Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Plague Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Plague Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Plague Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Plague Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Plague Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Plague Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Plague Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Plague Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Plague Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Plague Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Plague Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Plague Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Plague Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. CordenPharma Company Details
Table 47. CordenPharma Business Overview
Table 48. CordenPharma Plague Therapeutics Product
Table 49. CordenPharma Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 50. CordenPharma Recent Development
Table 51. Cipher Pharmaceuticals Company Details
Table 52. Cipher Pharmaceuticals Business Overview
Table 53. Cipher Pharmaceuticals Plague Therapeutics Product
Table 54. Cipher Pharmaceuticals Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Cipher Pharmaceuticals Recent Development
Table 56. Pfizer Company Details
Table 57. Pfizer Business Overview
Table 58. Pfizer Plague Therapeutics Product
Table 59. Pfizer Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Bayer HealthCare Company Details
Table 62. Bayer HealthCare Business Overview
Table 63. Bayer HealthCare Plague Therapeutics Product
Table 64. Bayer HealthCare Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Bayer HealthCare Recent Development
Table 66. Eli Lilly Company Details
Table 67. Eli Lilly Business Overview
Table 68. Eli Lilly Plague Therapeutics Product
Table 69. Eli Lilly Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 70. Eli Lilly Recent Development
Table 71. Achaogen Company Details
Table 72. Achaogen Business Overview
Table 73. Achaogen Plague Therapeutics Product
Table 74. Achaogen Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Achaogen Recent Development
Table 76. Aurobindo Pharma Company Details
Table 77. Aurobindo Pharma Business Overview
Table 78. Aurobindo Pharma Plague Therapeutics Product
Table 79. Aurobindo Pharma Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Aurobindo Pharma Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Plague Therapeutics Product
Table 84. GlaxoSmithKline Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Plague Therapeutics Product
Table 89. Bristol-Myers Squibb Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Development
Table 91. Aspen Pharmacare Company Details
Table 92. Aspen Pharmacare Business Overview
Table 93. Aspen Pharmacare Plague Therapeutics Product
Table 94. Aspen Pharmacare Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Aspen Pharmacare Recent Development
Table 96. Biocon Company Details
Table 97. Biocon Business Overview
Table 98. Biocon Plague Therapeutics Product
Table 99. Biocon Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Biocon Recent Development
Table 101. Astellas Pharma Company Details
Table 102. Astellas Pharma Business Overview
Table 103. Astellas Pharma Plague Therapeutics Product
Table 104. Astellas Pharma Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 105. Astellas Pharma Recent Development
Table 106. Melinta Therapeutics Company Details
Table 107. Melinta Therapeutics Business Overview
Table 108. Melinta Therapeutics Plague Therapeutics Product
Table 109. Melinta Therapeutics Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 110. Melinta Therapeutics Recent Development
Table 111. Basilea Pharmaceutica Company Details
Table 112. Basilea Pharmaceutica Business Overview
Table 113. Basilea Pharmaceutica Plague Therapeutics Product
Table 114. Basilea Pharmaceutica Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 115. Basilea Pharmaceutica Recent Development
Table 116. Allergan Company Details
Table 117. Allergan Business Overview
Table 118. Allergan Plague Therapeutics Product
Table 119. Allergan Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 120. Allergan Recent Development
Table 121. Abbott Company Details
Table 122. Abbott Business Overview
Table 123. Abbott Plague Therapeutics Product
Table 124. Abbott Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 125. Abbott Recent Development
Table 126. AstraZeneca Company Details
Table 127. AstraZeneca Business Overview
Table 128. AstraZeneca Plague Therapeutics Product
Table 129. AstraZeneca Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 130. AstraZeneca Recent Development
Table 131. AmpliPhi Biosciences Company Details
Table 132. AmpliPhi Biosciences Business Overview
Table 133. AmpliPhi Biosciences Plague Therapeutics Product
Table 134. AmpliPhi Biosciences Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 135. AmpliPhi Biosciences Recent Development
Table 136. Actelion Pharmaceuticals Company Details
Table 137. Actelion Pharmaceuticals Business Overview
Table 138. Actelion Pharmaceuticals Plague Therapeutics Product
Table 139. Actelion Pharmaceuticals Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 140. Actelion Pharmaceuticals Recent Development
Table 141. Chiesi Farmaceutici Company Details
Table 142. Chiesi Farmaceutici Business Overview
Table 143. Chiesi Farmaceutici Plague Therapeutics Product
Table 144. Chiesi Farmaceutici Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 145. Chiesi Farmaceutici Recent Development
Table 146. Exoxemis Company Details
Table 147. Exoxemis Business Overview
Table 148. Exoxemis Plague Therapeutics Product
Table 149. Exoxemis Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 150. Exoxemis Recent Development
Table 151. Merck Company Details
Table 152. Merck Business Overview
Table 153. Merck Plague Therapeutics Product
Table 154. Merck Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 155. Merck Recent Development
Table 156. DynPort Vaccine Company LLC Company Details
Table 157. DynPort Vaccine Company LLC Business Overview
Table 158. DynPort Vaccine Company LLC Plague Therapeutics Product
Table 159. DynPort Vaccine Company LLC Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)
Table 160. DynPort Vaccine Company LLC Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 164. Authors List of This Report
List of Figures
Figure 1. Plague Therapeutics Picture
Figure 2. Global Plague Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Plague Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Vaccine Features
Figure 5. Drugs Features
Figure 6. Global Plague Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Plague Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Plague Therapeutics Report Years Considered
Figure 12. Global Plague Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Plague Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Plague Therapeutics Market Share by Region: 2024 VS 2031
Figure 15. Global Plague Therapeutics Market Share by Players in 2024
Figure 16. Global Top Plague Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plague Therapeutics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Plague Therapeutics Revenue in 2024
Figure 18. North America Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Plague Therapeutics Market Share by Country (2020-2031)
Figure 20. United States Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Plague Therapeutics Market Share by Country (2020-2031)
Figure 24. Germany Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Plague Therapeutics Market Share by Region (2020-2031)
Figure 32. China Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Plague Therapeutics Market Share by Country (2020-2031)
Figure 40. Mexico Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Plague Therapeutics Market Share by Country (2020-2031)
Figure 44. Turkey Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. CordenPharma Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 48. Cipher Pharmaceuticals Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 50. Bayer HealthCare Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 51. Eli Lilly Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 52. Achaogen Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 53. Aurobindo Pharma Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 56. Aspen Pharmacare Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 57. Biocon Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 58. Astellas Pharma Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 59. Melinta Therapeutics Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 60. Basilea Pharmaceutica Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 61. Allergan Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 62. Abbott Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 63. AstraZeneca Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 64. AmpliPhi Biosciences Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 65. Actelion Pharmaceuticals Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 66. Chiesi Farmaceutici Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 67. Exoxemis Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 68. Merck Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 69. DynPort Vaccine Company LLC Revenue Growth Rate in Plague Therapeutics Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232